• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肠道消化模型中加入胃部步骤可改善两种脂质体药物递送系统在比格犬体内药代动力学数据的预测。

Adding a Gastric Step to the Intestinal Digestion Model Improves the Prediction of Pharmacokinetic Data in Beagle Dogs of Two Lipid-Based Drug Delivery Systems.

作者信息

Klitgaard Mette, Beilles Stephane, Sassene Philip Jonas, Berthelsen Ragna, Müllertz Anette

机构信息

Department of Pharmacy, University of Copenhagen, Copenhagen 2100, Denmark.

Pharmaceutical Science Department, Sanofi, Montpellier 34080, France.

出版信息

Mol Pharm. 2020 Sep 8;17(9):3214-3222. doi: 10.1021/acs.molpharmaceut.0c00307. Epub 2020 Aug 5.

DOI:10.1021/acs.molpharmaceut.0c00307
PMID:32662647
Abstract

Drug release from a lipid-based drug delivery system (LbDDS) is typically studied using a one-step intestinal digestion model. However, lately the importance of incorporating gastric digestion has been stressed. The aim of the present study was to compare a two-step gastro-intestinal (GI) digestion model to the commonly used one-step intestinal digestion model. The models were evaluated by studying release of the model drug A1260 from two LbDDSs (F-I and F-II), for which pharmacokinetic data from oral administration to beagle dogs were available. The amount of A1260 recovered in the aqueous phases during and after the GI digestion of F-I and F-II was related to the and AUC of the plasma concentration-time profiles of each formulation and produced a rank order - (IVIV) relation. In comparison, a similar IVIV rank ordering was obtained when relating the amount of A1260 recovered in the aqueous phase prior ( = 0 min), and following 15 min of intestinal digestion, to the plasma concentration-time profiles. However, after 60 min of intestinal digestion, the LbDDSs performed equally in the one-step digestion model, contrary to what was observed in the two-step digestion model, and . As the GI digestion model produced a clearer distinction in terms of LbDDS rank ordering of the two LbDDSs, compared to the intestinal digestion model, it was found to be a promising model to study and estimate the LbDDS behavior .

摘要

基于脂质的药物递送系统(LbDDS)的药物释放通常采用一步肠道消化模型进行研究。然而,最近已强调了纳入胃消化的重要性。本研究的目的是将两步胃肠道(GI)消化模型与常用的一步肠道消化模型进行比较。通过研究模型药物A1260从两种LbDDS(F-I和F-II)中的释放来评估这些模型,对于这两种LbDDS,有从口服给予比格犬获得的药代动力学数据。在F-I和F-II的GI消化期间及之后水相中回收的A1260量与每种制剂的血浆浓度-时间曲线的 和AUC相关,并产生了等级顺序 - (体内-体外)关系。相比之下,当将在水相中在之前( = 0分钟)以及在肠道消化15分钟后回收的A1260量与血浆浓度-时间曲线相关联时,获得了类似的体内-体外等级排序。然而,在肠道消化60分钟后,LbDDS在一步消化模型中的表现相同,这与在两步消化模型中观察到的情况相反,以及 。由于与肠道消化模型相比,GI消化模型在两种LbDDS的LbDDS等级排序方面产生了更明显的区别,因此发现它是研究和估计LbDDS行为的一个有前景的模型。

相似文献

1
Adding a Gastric Step to the Intestinal Digestion Model Improves the Prediction of Pharmacokinetic Data in Beagle Dogs of Two Lipid-Based Drug Delivery Systems.在肠道消化模型中加入胃部步骤可改善两种脂质体药物递送系统在比格犬体内药代动力学数据的预测。
Mol Pharm. 2020 Sep 8;17(9):3214-3222. doi: 10.1021/acs.molpharmaceut.0c00307. Epub 2020 Aug 5.
2
Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.采用体外脂肪酶水解和 SPECT/CT 体内成像技术了解贝特类药物从基于脂质的药物传递系统的口服吸收。
J Control Release. 2020 Jan 10;317:375-384. doi: 10.1016/j.jconrel.2019.11.024. Epub 2019 Nov 23.
3
In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).模拟儿科人群(新生儿和幼儿)胃肠道消化的体外模型
AAPS PharmSciTech. 2017 Feb;18(2):317-329. doi: 10.1208/s12249-016-0649-1. Epub 2016 Oct 28.
4
In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.基于脂质的药物递送系统中难溶性药物的体内沉淀
Mol Pharm. 2016 Oct 3;13(10):3417-3426. doi: 10.1021/acs.molpharmaceut.6b00413. Epub 2016 Aug 30.
5
Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?脂肪对犬体内卡维地洛吸收的影响:与脂肪制剂相比,同时给予脂肪是否同样有效?
J Control Release. 2019 Jun 28;304:90-100. doi: 10.1016/j.jconrel.2019.04.038. Epub 2019 Apr 29.
6
High-Throughput Lipolysis in 96-Well Plates for Rapid Screening of Lipid-Based Drug Delivery Systems.96孔板中的高通量脂解用于基于脂质的药物递送系统的快速筛选
J Pharm Sci. 2017 Apr;106(4):1183-1186. doi: 10.1016/j.xphs.2016.12.026. Epub 2017 Jan 3.
7
An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.一项反映大鼠肠道状况的体外消化试验,以探究制剂消化与首过代谢对基于脂质的制剂中达那唑生物利用度的重要性。
Mol Pharm. 2014 Nov 3;11(11):4069-83. doi: 10.1021/mp500197b. Epub 2014 Sep 29.
8
Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.开发一种用于快速筛选脂质体药物递送系统的高通量体外肠道脂解模型。
Eur J Pharm Biopharm. 2015 Aug;94:493-500. doi: 10.1016/j.ejpb.2015.06.028. Epub 2015 Jul 6.
9
Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.脂质相关的口服给药:口服吸收增强的机制与分析
J Control Release. 2016 Oct 28;240:544-560. doi: 10.1016/j.jconrel.2016.07.050. Epub 2016 Aug 9.
10
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.将 CETP 抑制剂 CP-532,623 的脂质体制剂的体外溶解和超饱和度曲线与体内暴露相关联。
Mol Pharm. 2017 Dec 4;14(12):4525-4538. doi: 10.1021/acs.molpharmaceut.7b00660. Epub 2017 Nov 9.

引用本文的文献

1
The Advancement of In Vitro Lipolysis: Two-Step Flow-Through Method for the Evaluation of Lipid-Based Drug Delivery Systems.体外脂解的进展:用于评估脂质体药物递送系统的两步流通法
Pharmaceutics. 2025 Apr 23;17(5):545. doi: 10.3390/pharmaceutics17050545.
2
Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method.使用体外脂解-渗透法评估自纳米乳化药物递送系统的口服吸收情况。
Pharmaceutics. 2021 Apr 2;13(4):489. doi: 10.3390/pharmaceutics13040489.